Anti-cancer Drug Discovery: Update and Comparisons in Yeast, Drosophila, and Zebrafish

ISSN: 1874-4702 (Online)
ISSN: 1874-4672 (Print)

Volume 10, 4 Issues, 2017

Download PDF Flyer

Current Molecular Pharmacology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Michael Kahn
University of Southern California
1450 Biggy Street
Los Angeles, NRT 4501, CA 90033

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Anti-cancer Drug Discovery: Update and Comparisons in Yeast, Drosophila, and Zebrafish

Current Molecular Pharmacology, 7(1): 44-51.

Author(s): Guangxun Gao, Liang Chen and Chuanshu Huang.

Affiliation: Nelson Institute of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.


Discovery of novel cancer chemotherapeutics focuses on screening and identifying compounds that can target ‘cancer-specific’ biological processes while causing minimal toxicity to non-tumor cells. Alternatively, model organisms with highly conserved cancer-related cellular processes relative to human cells may offer new opportunities for anticancer drug discovery when combined with chemical screening. Some organisms used for chemotherapeutic discovery include yeast, Drosophila, and zebrafish which are similar in important ways relevant to cancer study but offer distinct advantages as well. Here, we describe these model attributes and the rationale for using them in cancer drug screening research.


Anti-cancer drug discovery, Drosophila, HTS, model organism, yeast, zebrafish.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 7
Issue Number: 1
First Page: 44
Last Page: 51
Page Count: 8
DOI: 10.2174/1874467207666140702113629

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science